Psilocybin, MDMA, and other substances may help patients with terminal conditions manage pain and find acceptance and a new ...

From 1967 to 1977, he implemented studies of psychotherapy research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center, including protocols designed to investigate the ...

Palliative care has proven to be one of the most promising fields for research on interventions with psychedelic substances ... In 10% of the studies, LSD and DPT were combined. Altogether, 347 ...

Prescriptions for psychedelic drugs are closer than ever for European patients grappling with complex mental health problems – but there are still a few thorny hurdles to contend with.

Bob and Renee Parsons cut a ribbon at the opening of the Parsons Center for Psychedelic Research. On the third floor of a Mount Sinai extension building in Manhattan’s Upper West Side ...

The study, which interviewed eight licensed therapists from Numinus Wellness clinics in Canada and the US, aimed to understand how their personal psychedelic experiences influenced their ...

A psychedelic drug similar to LSD has been found to reduce anxiety in mice by changing their brain activity. The drug, named DOI (2,5-dimethoxy-4-iodoamphetamine), was found to activate special ...

While preliminary, the findings align with a growing body of evidence indicating that psychedelic compounds like psilocybin can promote mental health by enhancing the brain's capacity for ...

Mount Sinai Health System this week celebrated the opening of an expansion of its psychedelic psychotherapy research center into a new location and announced a foundational $5 million gift from ...

In recent years, there has been much debate about the role of traditional therapy in psychedelic-assisted therapy. Some argue that the medicines are the primary agents of change, needing only ...